NCT03034408View on ClinicalTrials.gov

Nalmefene, Baclofen and Impulsivity in Subjects With Alcohol Use Disorder and Healthy Control Subjects

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 1, 2016

Primary Completion Date

December 17, 2018

Study Completion Date

December 17, 2018

Conditions

Alcohol Use Disorder

Interventions

DRUG

Nalmefene

DRUG

Baclofen

DRUG

Placebo Oral Capsule

Trial Locations (1)

1202

Service d'Addictologie, Hôpitaux Universitaires de Genève, Geneva

All Listed Sponsors

lead

Prof. Daniele Zullino

OTHER

NCT03034408 - Nalmefene, Baclofen and Impulsivity in Subjects With Alcohol Use Disorder and Healthy Control Subjects | Biotech Hunter | Biotech Hunter